In mCRPC patients with androgen receptor (AR) mutations, treatment with MRT-2359 in combination with enzalutamide led to a 100% PSA response rate ...
In mCRPC patients with androgen receptor (AR) mutations, treatment with MRT-2359 in combination with enzalutamide led to a 100% PSA response rate (5 of 5 patients) and a 100% disease control rate, ...
FG-3246 and enzalutamide combination therapy, in biomarker unselected patients with androgen receptor pathway inhibitor (ARPI)-treated, ...
An informational overview of publicly available disclosures for Magnesium Niacinamide Relief (MagnesiumFreeze) — covering ingredients, company policies, and what consumers researching topical nerve ...
SCULPT & LIFTTM pairs Restylane® Lyft or Restylane® Contour with Sculptra® to help restore a youthful appearance and your ...
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) is one of the best stocks to buy and hold for the next 6 months. On February 10, Guggenheim raised its price target for Praxis Precision Medicines Inc.
Bayer AG (BAYRY) announced an update on their ongoing clinical study.
Tagros Chemicals’ flubendiamide acquisition from Bayer signals a sharper global distribution strategy, strengthening market reach and customer access worldwide.
“Esomeprazole is a widely used treatment for heartburn and acid reflux, but it’s often a tongue-twister for customers, Niamh ...
Professor Pei-Qiang Huang's research group at Xiamen University recently reported the first reduction-cross-coupling reaction of aliphatic tertiary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results